Artículos de revistas sobre el tema "Anticancer drug treatment"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Anticancer drug treatment".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Alven, Sibusiso y Blessing Atim Aderibigbe. "The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment". Pharmaceutics 12, n.º 12 (15 de diciembre de 2020): 1212. http://dx.doi.org/10.3390/pharmaceutics12121212.
Texto completoSavinkova, A. V., E. M. Zhidkova, L. R. Tilova, M. D. Lavrova, E. S. Lylova, K. A. Kuzin, A. Yu Portyannikova et al. "VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT". Siberian journal of oncology 17, n.º 3 (4 de julio de 2018): 77–87. http://dx.doi.org/10.21294/1814-4861-2018-17-3-77-87.
Texto completoMahmud, Kazi Mustafa, Mahruba Sultana Niloy, Md Salman Shakil y Md Asiful Islam. "Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment". Pharmaceutics 13, n.º 8 (19 de agosto de 2021): 1295. http://dx.doi.org/10.3390/pharmaceutics13081295.
Texto completoLee, Jun H. y Anjan Nan. "Combination Drug Delivery Approaches in Metastatic Breast Cancer". Journal of Drug Delivery 2012 (26 de abril de 2012): 1–17. http://dx.doi.org/10.1155/2012/915375.
Texto completoP. George, Christy, Shridhar H. Thorat, Parth S. Shaligram, Suresha P. R. y Rajesh G. Gonnade. "Drug–drug cocrystals of anticancer drugs erlotinib–furosemide and gefitinib–mefenamic acid for alternative multi-drug treatment". CrystEngComm 22, n.º 37 (2020): 6137–51. http://dx.doi.org/10.1039/d0ce00353k.
Texto completoMoradi-Marjaneh, Reyhaneh, Majid Khazaei, Sima Seifi, Seyed Mahdi Hassanian, Gordon A. Ferns y Amir Avan. "Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer". Current Pharmaceutical Design 24, n.º 23 (24 de octubre de 2018): 2710–18. http://dx.doi.org/10.2174/1381612824666180727144535.
Texto completoOstroumova, O. D., D. A. Sychev, A. I. Kochetkov, T. M. Ostroumova, M. I. Kulikova y V. A. De. "Anti-cancer agents and drug-induced hypertension". Medical alphabet, n.º 17 (7 de septiembre de 2022): 30–41. http://dx.doi.org/10.33667/2078-5631-2022-17-30-41.
Texto completoLi, Fan, Xinqing Fu, Qingqing Huo y Wantao Chen. "Research Progress on the Nano-Delivery Systems of Antitumor Drugs". Nano LIFE 10, n.º 01n02 (marzo de 2020): 2040006. http://dx.doi.org/10.1142/s1793984420400061.
Texto completoFumagalli, Gaia, Cristina Marucci, Michael S. Christodoulou, Barbara Stella, Franco Dosio y Daniele Passarella. "Self-assembly drug conjugates for anticancer treatment". Drug Discovery Today 21, n.º 8 (agosto de 2016): 1321–29. http://dx.doi.org/10.1016/j.drudis.2016.06.018.
Texto completoKim, Tae-Hyun, Gyeong Jin Lee, Joo-Hee Kang, Hyoung-Jun Kim, Tae-il Kim y Jae-Min Oh. "Anticancer Drug-Incorporated Layered Double Hydroxide Nanohybrids and Their Enhanced Anticancer Therapeutic Efficacy in Combination Cancer Treatment". BioMed Research International 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/193401.
Texto completoSingh, A., S. Bhatia y V. Rana. "Inhalable Nanostructures for Lung Cancer Treatment: Progress and Challenges". Current Nanomedicine 9, n.º 1 (15 de marzo de 2019): 4–29. http://dx.doi.org/10.2174/2468187308666180307152049.
Texto completoGurunathan, Sangiliyandi, Min-Hee Kang, Muhammad Qasim y Jin-Hoi Kim. "Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer". International Journal of Molecular Sciences 19, n.º 10 (20 de octubre de 2018): 3264. http://dx.doi.org/10.3390/ijms19103264.
Texto completoKumar, Maushmi S., Tanuja T. Yadav, Rohan R. Khair, Godefridus J. Peters y Mayur C. Yergeri. "Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment". Current Pharmaceutical Design 25, n.º 31 (14 de noviembre de 2019): 3323–38. http://dx.doi.org/10.2174/1381612825666190902155957.
Texto completoSultana, Tania, Umair Jan y Jeong Ik Lee. "Double Repositioning: Veterinary Antiparasitic to Human Anticancer". International Journal of Molecular Sciences 23, n.º 8 (13 de abril de 2022): 4315. http://dx.doi.org/10.3390/ijms23084315.
Texto completoRamachandiran, Balaji, Biswajit Dubashi, Smita Kayal, Vikas Menon, K. Yuvaraj, C. Deepika, Deepa Francis, Deeksha Debbarma y Devika S. Nair. "Assessment of Oral Anticancer Medication Adherence: A Survey from a Tertiary Cancer Center". South Asian Journal of Cancer 10, n.º 02 (abril de 2021): 127–30. http://dx.doi.org/10.1055/s-0041-1723120.
Texto completoKumar, Girish, Tarun Virmani, Ashwani Sharma y Kamla Pathak. "Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers". Pharmaceutics 15, n.º 3 (9 de marzo de 2023): 889. http://dx.doi.org/10.3390/pharmaceutics15030889.
Texto completoRohit Deepak Nalawade y Bhagwan Dilip Devkar. "Olaparib an anticancer drug: A review". World Journal of Advanced Research and Reviews 11, n.º 2 (30 de agosto de 2021): 329–36. http://dx.doi.org/10.30574/wjarr.2021.11.2.0406.
Texto completoElekofehinti, Olusola Olalekan, Opeyemi Iwaloye, Femi Olawale y Esther Opeyemi Ariyo. "Saponins in Cancer Treatment: Current Progress and Future Prospects". Pathophysiology 28, n.º 2 (5 de junio de 2021): 250–72. http://dx.doi.org/10.3390/pathophysiology28020017.
Texto completoFulda, Simone. "Targeting autophagy for the treatment of cancer". Biological Chemistry 399, n.º 7 (27 de junio de 2018): 673–77. http://dx.doi.org/10.1515/hsz-2018-0105.
Texto completoVisconti, Roberta y Domenico Grieco. "Fighting tubulin-targeting anticancer drug toxicity and resistance". Endocrine-Related Cancer 24, n.º 9 (septiembre de 2017): T107—T117. http://dx.doi.org/10.1530/erc-17-0120.
Texto completoNg, Chau Yee, Chun-Bing Chen, Ming-Ying Wu, Jennifer Wu, Chih-Hsun Yang, Rosaline Chung-Yee Hui, Ya-Ching Chang y Chun-Wei Lu. "Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies". Journal of Immunology Research 2018 (2018): 1–9. http://dx.doi.org/10.1155/2018/5376476.
Texto completoMajumder, Nairrita, Nandita G Das y Sudip K. Das. "Polymeric micelles for anticancer drug delivery". Therapeutic Delivery 11, n.º 10 (octubre de 2020): 613–35. http://dx.doi.org/10.4155/tde-2020-0008.
Texto completoAhtit, Mustapha, Soulaymani Abdelmajid, Khadmaoui Abderrazak, R. Benkirane, Soulaymani Bencheikh Rachida y E. Kerak. "Les Effets Indésirables Digestifs De La Chimiothérapie : Cas Des Patients De L’institut National D’oncologie De Rabat (Maroc)". European Scientific Journal, ESJ 12, n.º 33 (30 de noviembre de 2016): 454. http://dx.doi.org/10.19044/esj.2016.v12n33p454.
Texto completoIbrahim, Hassan M., Omar A. Farid, Amany Samir y Rehab M. Mosaad. "Preparation of Chitosan Antioxidant Nanoparticles as Drug Delivery System for Enhancing of Anti-Cancer Drug". Key Engineering Materials 759 (enero de 2018): 92–97. http://dx.doi.org/10.4028/www.scientific.net/kem.759.92.
Texto completoWang, Ying y Jen-Fu Chiu. "Proteomic Approaches in Understanding Action Mechanisms of Metal-Based Anticancer Drugs". Metal-Based Drugs 2008 (22 de julio de 2008): 1–9. http://dx.doi.org/10.1155/2008/716329.
Texto completoAlven, Sibusiso, Xhamla Nqoro, Buhle Buyana y Blessing A. Aderibigbe. "Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer". Pharmaceutics 12, n.º 5 (29 de abril de 2020): 406. http://dx.doi.org/10.3390/pharmaceutics12050406.
Texto completoMeegan, Mary J. y Niamh M. O’Boyle. "Special Issue “Anticancer Drugs”". Pharmaceuticals 12, n.º 3 (16 de septiembre de 2019): 134. http://dx.doi.org/10.3390/ph12030134.
Texto completoLee, Jae-Seon, Ho Lee, Hyonchol Jang, Sang Myung Woo, Jong Bae Park, Seon-Hyeong Lee, Joon Hee Kang, Hee Yeon Kim, Jaewhan Song y Soo-Youl Kim. "Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling". Cells 9, n.º 9 (1 de septiembre de 2020): 2013. http://dx.doi.org/10.3390/cells9092013.
Texto completoFranzese, Ornella, Francesco Torino, Elisa Giannetti, Giorgia Cioccoloni, Angelo Aquino, Isabella Faraoni, Maria Pia Fuggetta et al. "Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?" International Journal of Molecular Sciences 22, n.º 19 (1 de octubre de 2021): 10672. http://dx.doi.org/10.3390/ijms221910672.
Texto completoTang, Lu, Jing Li, Qingqing Zhao, Ting Pan, Hui Zhong y Wei Wang. "Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery". Pharmaceutics 13, n.º 8 (27 de julio de 2021): 1151. http://dx.doi.org/10.3390/pharmaceutics13081151.
Texto completoOstroumova, O. D., M. S. Chernyaeva, A. I. Kochetkov, D. I. Bakhteeva, S. N. Ivanov y D. A. Sychev. "Atrial Fibrillation Associated with Anticancer Drugs". Safety and Risk of Pharmacotherapy 8, n.º 4 (17 de diciembre de 2020): 178–90. http://dx.doi.org/10.30895/2312-7821-2020-8-4-178-190.
Texto completoYu, Guo, Dan-Na Wu, Yichao Yu, Guo-Fu Li y Hong-Hao Zhou. "Impact of dosage timing on the bioavailability of oral anticancer medications: Is pre-prandial dosing equivalent to post-prandial dosing". Journal of Oncology Pharmacy Practice 25, n.º 2 (17 de enero de 2018): 404–8. http://dx.doi.org/10.1177/1078155217752535.
Texto completoTorić, Jelena, Ana Karković Marković, Cvijeta Jakobušić Brala y Monika Barbarić. "Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs". Acta Pharmaceutica 69, n.º 4 (1 de diciembre de 2019): 461–82. http://dx.doi.org/10.2478/acph-2019-0052.
Texto completoRahmania, Fitriani Jati, Yi-Shou Huang, Yitayal Admassu Workie, Toyoko Imae, Anna Kondo, Yukiko Miki, Ritsuko Imai et al. "Preparation of Functional Nanoparticles-Loaded Magnetic Carbon Nanohorn Nanocomposites towards Composite Treatment". Nanomaterials 13, n.º 5 (23 de febrero de 2023): 839. http://dx.doi.org/10.3390/nano13050839.
Texto completoSzumilak, Marta, Anna Wiktorowska-Owczarek y Andrzej Stanczak. "Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?" Molecules 26, n.º 9 (29 de abril de 2021): 2601. http://dx.doi.org/10.3390/molecules26092601.
Texto completoHao, Jessica, Ivana Stavljenić Milašin, Zeynep Batu Eken, Marinka Mravak-Stipetic, Krešimir Pavelić y Fusun Ozer. "Effects of Zeolite as a Drug Delivery System on Cancer Therapy: A Systematic Review". Molecules 26, n.º 20 (14 de octubre de 2021): 6196. http://dx.doi.org/10.3390/molecules26206196.
Texto completoTaghipour-Sabzevar, Vahid, Tahere Sharifi y Mehrdad Moosazadeh Moghaddam. "Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents". Therapeutic Delivery 10, n.º 8 (agosto de 2019): 527–50. http://dx.doi.org/10.4155/tde-2019-0044.
Texto completoOstroumova, Olga D., Aleksey I. Kochetkov y Valeria A. De. "Cancer treatment and drug-induced QT interval prolongation: A review". Consilium Medicum 24, n.º 6 (15 de agosto de 2022): 391–98. http://dx.doi.org/10.26442/20751753.2022.6.201542.
Texto completoXiao, Yuchen, Jianping Yong, Yang Yang y Canzhong Lu. "The Ethyl Acetate Extraction Obtained from Podocarpus Nagikernel Meal with Anticancer Activity". Biomedical and Pharmacology Journal 14, n.º 1 (30 de marzo de 2021): 363–66. http://dx.doi.org/10.13005/bpj/2134.
Texto completoKumar, Sahil, Bandna Sharma, Kiran Thakur, Tilak R. Bhardwaj, Deo N. Prasad y Rajesh K. Singh. "Recent Advances in the Development of Polymeric Nanocarrier Formulations for the Treatment of Colon Cancer". Drug Delivery Letters 9, n.º 1 (6 de febrero de 2019): 2–14. http://dx.doi.org/10.2174/2210303108666181109120710.
Texto completoQi, Jiating y Zhuqing Ouyang. "Targeting CDK4/6 for Anticancer Therapy". Biomedicines 10, n.º 3 (16 de marzo de 2022): 685. http://dx.doi.org/10.3390/biomedicines10030685.
Texto completoNikolova, Maria P., Enamala Manoj Kumar y Murthy S. Chavali. "Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment". Pharmaceutics 14, n.º 10 (15 de octubre de 2022): 2195. http://dx.doi.org/10.3390/pharmaceutics14102195.
Texto completoAlven, Sibusiso y Blessing Atim Aderibigbe. "Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs". Nanomaterials 10, n.º 8 (8 de agosto de 2020): 1556. http://dx.doi.org/10.3390/nano10081556.
Texto completoKrasnopolsky, Yu, D. Pylypenko y G. Grigoryeva. "NANOMEDICINE IN ANTICANCER THERAPY". Bulletin of the National Technical University "KhPI". Series: Chemistry, Chemical Technology and Ecology 1, n.º 7 (30 de diciembre de 2022): 3–13. http://dx.doi.org/10.20998/2079-0821.2022.01.
Texto completoWang, Jianzheng, Jinxi Huang, Hui Wang, Wei Yang, Qiwen Bai, Zhentao Yao, Qingli Li et al. "Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model". Journal of Oncology 2022 (27 de enero de 2022): 1–11. http://dx.doi.org/10.1155/2022/1987705.
Texto completoGori, Stefania, Massimo Di Maio, Carmine Pinto, Oscar Alabiso, Editta Baldini, Enrico Barbato, Giordano Domenico Beretta et al. "Impact of use of Oral Anticancer Drugs on Activity of Italian Oncology Practices: Results of a Survey Conducted by the Italian Society of Medical Oncology (AIOM)". Tumori Journal 99, n.º 1 (enero de 2013): 35–38. http://dx.doi.org/10.1177/030089161309900106.
Texto completoGyanani, Vijay, Jeffrey C. Haley y Roshan Goswami. "Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems". Pharmaceuticals 14, n.º 9 (24 de agosto de 2021): 835. http://dx.doi.org/10.3390/ph14090835.
Texto completoBepari, Asmatanzeem, Nayana Sakre, Ishrat Rahman, Shaik Kalimulla Niazi y Asmabi M. Dervesh. "The Assessment of Drug Utilization Study of Anticancer Drugs Using WHO Prescribing Indicators in a Government Tertiary Care Hospital of the Hyderabad - Karnataka Region of India". Open Access Macedonian Journal of Medical Sciences 7, n.º 7 (13 de abril de 2019): 1203–8. http://dx.doi.org/10.3889/oamjms.2019.249.
Texto completoJiang, Bing-Hua y Ling-Zhi Liu. "Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment". Drug Resistance Updates 11, n.º 3 (junio de 2008): 63–76. http://dx.doi.org/10.1016/j.drup.2008.03.001.
Texto completoRogala, Britny G., Margaret M. Charpentier, Michelle K. Nguyen, Kaitlin M. Landolf, Lamya Hamad y Kelly M. Gaertner. "Oral Anticancer Therapy: Management of Drug Interactions". Journal of Oncology Practice 15, n.º 2 (febrero de 2019): 81–90. http://dx.doi.org/10.1200/jop.18.00483.
Texto completo